03681.HK
SinoMab BioScience Limited
HKSE · Healthcare · Biotechnology · HK
HKD 1.15
+0.88%Margins
Gross margin
100.0%
EBITDA margin
-4828.9%
EBIT margin
-5125.7%
Net margin
-5694.3%
FCF margin
-1672.4%
-90.2%
Return on equity
-47.6%
Return on assets
-46.7%
Return on invested capital
0.01x
Asset turnover
-HKD 82.1M
Cash from operations
HKD 0.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026